Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80

African Journal of Biotechnology

Volumn 10, Issue 9, 2011, Pages 1684-1689

  How, Chee Wun ^a   Abdullah, Rasedee ^a   Abbasalipourkabir, Roghayeh ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colloidal delivery system; Highpressure homogenization; Nanostructured lipid carriers; Physicochemical properties; Polysorbate 20; Polysorbate 80

Indexed keywords

CRYSTALLIN; NANOMATERIAL; POLYSORBATE 20; POLYSORBATE 80;

ARTICLE; COLLOID; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; MELTING POINT; MOLECULAR STABILITY; NANOFABRICATION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 79952301601     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. AL-Haj N, Rasedee A, Ibrahim S, Bustaman A (2008). Tamoxifen drug loading solid lipid nanoparticles prepared by hot high-pressure homogenization techniques. Am. J. Pharmacol. Toxicol. 3(3): 219-244.
2. Burgess DJ (2006). Colloids and colloid drug delivery system. Encyclopedia of Pharmaceutical Technology, Third Edition, London: Informa Healthcare. pp. 636-647.
3. Dingler A (1998). Feste lipid-nanopartikel als kolloidale wirkstofftragersysteme zur dermalen applikation. Phd thesis, Berlin.
4. Dong ZH, Chang SX, Kai JH, Chang HZ (2003). The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 24: 1781-1785.
5. Freitas C, Müller RH (1999). Correlation between long-term stability of Solid Lipid Nanoparticles (SLN) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 47: 125-132.
6. Gupta RB (2006). Fundamentals of Drug Nanoparticles. In Gupta RB, Kompella UB (Eds). Drug and the pharmaceutical sciences: nanoparticle technology for drug delivery. New York: Taylor and Francis. pp. 1-18.
7. Hunter RJ (1986). Foundations of colloidal science. Oxford: Oxford University Press.
8. Jenning V, Thunemann AF, Gohla SH (2000). Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 199: 167-177.
9. Kuntsche J, Westesen K, Drechsler M, Koch MH, Bunjes H (2004). Supercooled smetic nanoparticles: a potential novel carrier system for poorly water soluble drugs. Pharm. Res. 21: 1834-1843.
10. Mathur V, Satrawala Y, Rajput MS, Kumar P, Shrivastava P, Vishvkarma A (2010). Solid lipid nanoparticles in cancer therapy. Int. J. Drug Delivery. 2: 192-199.
11. Müller RH, Mader K, Gohla S (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art. Eur. J. Pharm. Biopharm. 50: 161-177.
12. Müller RH, Radtke M, Wissing SA (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 242: 121-128.
13. Müller RH, Radtke M, Wissing SA (2004). Solid lipid nanoparticles and nanostructured lipid carriers. In Nalwa HS (Eds). Los Angeles, California: American Scientific Publisers. Encyclopedia Nanosci. Nanotechnol. pp. 43-56.
14. Muhlen ZA, Schwarz C, Mehnert W (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm. 45: 149-155.
15. Nanda KK, Maisels A, Kruis FE, Fissan H, Stappert S (2003). High surface energy of free nanoparticles. Phys. Rev. Lett. 91(10): 1061021-1061024.
16. Radomska-Soukharev A (2007). Stability of lipid excipients in solid lipid nanoparticles. Adv. Drug Deliv. Rev. 59: 411-418. DOI:10.1016/j.addr.2007.04.004
17. Souto EB, Müller RH (2006). Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot highpressure homogenization. J. Microencapsul. 23: 377-388.
18. Souto EB, Müller RH (2007). Lipid Nanoparticles (Solid Lipid Nanoparticles and Nanostructured Lipid Carriers) for Cosmetic, Dermal, and Transdermal Applications. In: Thassu D, Deleers M, Pathak Y (Eds). Drugs and the Pharmaceutical Science: Nanoparticulate Drug Delivery Systems pp. 213-234. North Carolina: Pharmaceut. Tech, Inc.
19. Westesen K, Siekmann B (1997). Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int. J. Pharm. 151: 35-45.
20. Westesen K, Bunjes H, Koch MH (1997). Physiocochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control Release, 48: 223-236.
21. Zauner W, Farrow NA, Haines AM (2001). In vitro uptake of polystyrene microspheres: effect of particle size cell line and cell density. J. Control Release, 71: 39-51.